Why the study?
Does percutaneous implantation of an entirely intracardiac leadless pacemaker meet pacing and sensing requirements in patients?
Does percutaneous implantation of an entirely intracardiac leadless pacemaker meet pacing and sensing requirements in patients?
Answers are grounded in this paper and cite their sources.
An entirely intracardiac leadless pacemaker successfully met pacing and sensing requirements, though device-related serious adverse events occurred in roughly 6.6% of patients.
The leadless cardiac pacemaker met prespecified pacing and sensing requirements in the large majority of patients. Device-related serious adverse events occurred in approximately 1 in 15 patients. (Funded by St. Jude Medical; LEADLESS II ClinicalTrials.gov number, NCT02030418.).
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: